McKesson Corp. Stock
McKesson Corp. Stock
There is an upward development for McKesson Corp. compared to yesterday, with an increase of €7.60 (1.090%).
With 29 Buy predictions and not a single Sell prediction McKesson Corp. is an absolute favorite of our community.
With a target price of 720 € there is a slightly positive potential of 2.65% for McKesson Corp. compared to the current price of 701.4 €.
Pros and Cons of McKesson Corp. in the next few years
Pros
?
C******** o* t** e**********
?
M***** P*******
?
S********** s********
Cons
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of McKesson Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| McKesson Corp. | 1.090% | -0.199% | 2.574% | 22.580% | -0.595% | 97.022% | 366.977% |
| Cardinal Health Inc. | -0.660% | -1.566% | 1.408% | 45.742% | -1.901% | 139.139% | 277.938% |
| CVS Health Corp. | -0.220% | 0.921% | 2.541% | 52.778% | 1.277% | -19.107% | 12.688% |
| AmerisourceBergen Corp. | -0.160% | -0.277% | -0.569% | 25.108% | 0.035% | 87.630% | 220.556% |
Comments
McKesson (NYSE:MCK) had its "buy" rating reaffirmed by analysts at Cowen Inc.
Show more
Ratings data for MCK provided by MarketBeat
McKesson (NYSE:MCK) had its "buy" rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft.
Show more
Ratings data for MCK provided by MarketBeat
McKesson (NYSE:MCK) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
Show more
Ratings data for MCK provided by MarketBeat